Skip to search formSkip to main contentSkip to account menu

SC 560

Known as: SC-560, SC560 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
BackgroundCOX inhibitors and β-blockers were recently suggested to reduce cancer progression through inhibition of tumor… 
Highly Cited
2006
Highly Cited
2006
Local increase in blood flow during neural activity forms the basis for functional brain imaging, but its mechanism remains… 
Highly Cited
2002
Highly Cited
2002
COX2-selective non-steroidal anti-inflammatory drugs (NSAIDs) cause selective apoptosis of renal medullary interstitial cells… 
Highly Cited
2001
Highly Cited
2001
The regular use of various nonsteroidal anti‐inflammatory drugs (NSAIDs) was shown to decrease the incidence of colorectal cancer… 
Highly Cited
2001
Highly Cited
2001
The clinical use of doxorubicin, an anthracycline chemotherapeutic agent, is limited by cardiotoxicity, particularly when… 
Highly Cited
2000
Highly Cited
2000
BACKGROUND & AIMS Selective cyclooxygenase (COX)-2 inhibitors produce less gastric damage than conventional nonsteroidal anti… 
Highly Cited
1998
Highly Cited
1998
The enzymes cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) catalyze the conversion of arachidonic acid to prostaglandin…